Lifen Kuang

No. 58, Zhongshan 2Nd Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Clinical implications and predictors of MRD resurgence in ASCT-eligible patients with NDMM: a real-world study in China.

Clinical implications and predictors of MRD resurgence in ASCT-eligible patients with NDMM: a real-world study in China.

Journal: Future oncology (London, England)

Published: June 12, 2026

Sustained MRD Negative for 4 Years Is a Significant Marker of Prognosis in Patients with High-Risk Multiple Myeloma.

Sustained MRD Negative for 4 Years Is a Significant Marker of Prognosis in Patients with High-Risk Multiple Myeloma.

Journal: Cancers

Published: March 31, 2026

Risk stratification, treatment patterns and survival outcomes in newly diagnosed multiple myeloma patients: A real-world analysis from the Chinese Myeloma Committee.

Risk stratification, treatment patterns and survival outcomes in newly diagnosed multiple myeloma patients: A real-world analysis from the Chinese Myeloma Committee.

Journal: British journal of haematology

Published: February 11, 2026

Impact of early minimal residual disease assessment on the outcomes of patients with systemic light chain amyloidosis.

Impact of early minimal residual disease assessment on the outcomes of patients with systemic light chain amyloidosis.

Journal: Annals of medicine

Published: November 03, 2025

Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation.

Outcomes Among MM Patients Receiving Early Intervention for MRD Progression Following Autologous Stem Cell Transplantation.

Journal: Cancer medicine

Published: August 27, 2025

MASS-4 is more suitable than MASS-3 for prognostic stratification in transplant-eligible patients with newly diagnosed multiple myeloma.

MASS-4 is more suitable than MASS-3 for prognostic stratification in transplant-eligible patients with newly diagnosed multiple myeloma.

Journal: Annals of medicine

Published: July 02, 2025

Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive Nomogram.

Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive Nomogram.

Journal: Biomedicines

Published: December 05, 2024

The characteristics of patients with multiple myeloma surviving over 10 years.

The characteristics of patients with multiple myeloma surviving over 10 years.

Journal: Frontiers in oncology

Published: September 03, 2024

Clinical characteristics and risk factors of infection in initially treated patients with multiple myeloma during the induction period.

Clinical characteristics and risk factors of infection in initially treated patients with multiple myeloma during the induction period.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: June 29, 2024

Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma.

Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma.

Journal: British journal of haematology

Published: July 17, 2023

RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.

RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.

Journal: Medical oncology (Northwood, London, England)

Published: October 30, 2022

Cystathionine β Synthase/Hydrogen Sulfide Signaling in Multiple Myeloma Regulates Cell Proliferation and Apoptosis.

Cystathionine β Synthase/Hydrogen Sulfide Signaling in Multiple Myeloma Regulates Cell Proliferation and Apoptosis.

Journal: Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer

Published: September 01, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026